Form 4: Atlassian CEO Michael Cannon-Brookes Executes Stock Sales Under 10b5-1 Trading Plan
SEC Form 4 Filing
Atlassian CEO Michael Cannon-Brookes sold shares of Class A Common Stock on March 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Michael Cannon-Brookes, CEO and Co-Founder of Atlassian Corp, executed multiple sales of Class A Common Stock on March 21, 2025.
- The sales were conducted under a Rule 10b5-1 trading plan adopted on February 8, 2024.
- The transactions involved the disposal of shares held indirectly through the Cannon-Brookes Head Trust.
- The sales occurred at varying prices throughout the day, ranging from approximately $219.00 to $227.97 per share.
- A total of 54,431 shares were held by the trust after the transactions.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating stock sales by an insider under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transactions.
Industry Context
Sales by insiders are a common occurrence, especially when executed under pre-arranged trading plans like Rule 10b5-1. These plans allow insiders to sell shares over a period of time without being accused of trading on non-public information. The market typically views these sales in the context of the overall health and prospects of the company.
Key Dates
| Date | Description |
|---|---|
| 02/08/2024 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| 03/21/2025 | Date of the stock sale transactions |
| 03/24/2025 | Date of the Form 4 filing |
Keywords
Atlassian, Cannon-Brookes, Stock Sale, Form 4, 10b5-1 Trading Plan, Insider Trading, TEAM
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.